Forte Biosciences Inc
F:37TA

Watchlist Manager
Forte Biosciences Inc Logo
Forte Biosciences Inc
F:37TA
Watchlist
Price: 6.8 EUR
Market Cap: 247.8m EUR

37TA's latest stock split occurred on Aug 28, 2024

The company executed a 1-for-25 stock split, meaning that for every 25 shares held, investors received 1 new share.

Before the split, 37TA traded at 0.272 per share. Afterward, the share price was about 6.8.

The adjusted shares began trading on Aug 28, 2024. This was the only stock split in 37TA's history.

Last Splits:
Aug 28, 2024
1-for-25
Pre-Split Price
6.8 0.272
Post-Split Price
6.8
Before
After
Last Splits:
Aug 28, 2024
1-for-25

Forte Biosciences Inc
Stock Splits History

37TA Stock Splits Timeline
Aug 28, 2024
Aug 28, 2024
Split 1-for-25
/0.04
Pre-Split Price
6.8 0.272
Post-Split Price
6.8
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Jan 20, 2026
Linius Technologies Ltd
OTC:LNNTF
1-for-100
/100
0.0001 0.0001 USD N/A
Jan 20, 2026
Lotus Resources Ltd
OTC:LTSRF
1-for-11
/11
0.143 0.143 USD N/A
Jan 15, 2026
Amcor PLC
NYSE:AMCR
1-for-5
/5
8.4 8.4 USD N/A
Jan 8, 2026
Sumitomo Realty & Development Co Ltd
OTC:SURYY
2-for-1
x2
25.635 25.635 USD N/A
Jan 7, 2026
Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG
SWB:EFF
1-for-10
/10
0.35 0.35 EUR N/A
Load More

Forte Biosciences Inc
Glance View

Market Cap
247.8m EUR
Industry
Biotechnology

Forte Biosciences, Inc. is a clinical stage biopharmaceutical company focused on dermatology. The company is headquartered in Torrance, California and currently employs 5 full-time employees. The company went IPO on 2017-04-13. The firm is focused on its lead product candidate, FB-401, which is a topical live biotherapeutic for the treatment of inflammatory skin diseases, including pediatric and adult patients with atopic dermatitis (AD). FB401 was developed in collaboration with the National Institutes of Health (NIH), and the National Institute of Allergy and Infectious Diseases (NIAID). FB-401 has completed Phase I/II a testing in adult and pediatric patients with atopic dermatitis.

37TA Intrinsic Value
Not Available
Back to Top